#88 Lenvatinib Plus Pembrolizumab Versus Chemotherapy As First-Line Therapy for Advanced or Recurrent Endometrial Cancer: Primary Results of the Phase 3 ENGOT-en9/LEAP-001 Study
International Journal of Gynecological Cancer(2024)
Key words
Endometrial Carcinoma
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined